107 related articles for article (PubMed ID: 21346773)
1. Genetic variants in CTLA4 are strongly associated with alopecia areata.
John KK; Brockschmidt FF; Redler S; Herold C; Hanneken S; Eigelshoven S; Giehl KA; De Weert J; Lutz G; Kruse R; Wolff H; Blaumeiser B; Böhm M; Becker T; Nöthen MM; Betz RC
J Invest Dermatol; 2011 May; 131(5):1169-72. PubMed ID: 21346773
[No Abstract] [Full Text] [Related]
2. Cytotoxic T-lymphocyte antigen 4 (CTLA4) +49AG and CT60 gene polymorphisms in Alopecia Areata: a case-control association study in the Italian population.
Megiorni F; Mora B; Maxia C; Gerardi M; Pizzuti A; Rossi A
Arch Dermatol Res; 2013 Sep; 305(7):665-70. PubMed ID: 23567921
[TBL] [Abstract][Full Text] [Related]
3. CTLA4 +49AG (rs231775) and CT60 (rs3087243) gene variants are not associated with alopecia areata in a Mexican population from Monterrey Mexico.
Salinas-Santander MA; Cantu-Salinas CS; Ocampo-Candiani J; Suarez-Valencia VJ; Ramirez-Guerrero JG; Sanchez-Dominguez CN
An Bras Dermatol; 2020; 95(3):283-288. PubMed ID: 32278632
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide association study in alopecia areata implicates both innate and adaptive immunity.
Petukhova L; Duvic M; Hordinsky M; Norris D; Price V; Shimomura Y; Kim H; Singh P; Lee A; Chen WV; Meyer KC; Paus R; Jahoda CA; Amos CI; Gregersen PK; Christiano AM
Nature; 2010 Jul; 466(7302):113-7. PubMed ID: 20596022
[TBL] [Abstract][Full Text] [Related]
5. [Alopecia areata and vitiligo: Can genetics tell us more about their mechanisms?].
Dereure O
Ann Dermatol Venereol; 2010 Nov; 137(11):755-6. PubMed ID: 21074666
[No Abstract] [Full Text] [Related]
6. Association of Rs231775 Genetic Variant of Cytotoxic T-lymphocyte Associated Protein 4 with Alopecia Areata Disease in Males: A Case-Control Study.
Ismail NA; Toraih EA; Ameen HM; Gomaa AHA; Marie REM
Immunol Invest; 2021 Nov; 50(8):977-986. PubMed ID: 32731768
[TBL] [Abstract][Full Text] [Related]
7. Association of CTLA-4 gene polymorphisms and alopecia areata: a systematic review and meta-analysis.
Zhou B; Chen M; Shang S; Zhao J
Biomarkers; 2022 Jun; 27(4):338-348. PubMed ID: 35254172
[TBL] [Abstract][Full Text] [Related]
8. Genetic analysis of autoimmune regulator haplotypes in alopecia areata.
Wengraf DA; McDonagh AJ; Lovewell TR; Vasilopoulos Y; Macdonald-Hull SP; Cork MJ; Messenger AG; Tazi-Ahnini R
Tissue Antigens; 2008 Mar; 71(3):206-12. PubMed ID: 18194361
[TBL] [Abstract][Full Text] [Related]
9. Investigation of the functional variant c.-169T > C of the Fc receptor-like 3 (FCRL3) gene in alopecia areata.
Schäfer N; Blaumeiser B; Becker T; Freudenberg-Hua Y; Hanneken S; Eigelshoven S; Schmael C; Lambert J; De Weert J; Kruse R; Nöthen MM; Betz RC
Int J Immunogenet; 2006 Dec; 33(6):393-5. PubMed ID: 17117947
[TBL] [Abstract][Full Text] [Related]
10. Association between TLR1 polymorphisms and alopecia areata.
Seok H; Suh DW; Jo B; Lee HB; Jang HM; Park HK; Lew BL; Chung JH; Sim WY
Autoimmunity; 2014 Sep; 47(6):372-7. PubMed ID: 24780078
[TBL] [Abstract][Full Text] [Related]
11. Methylenetetrahydrofolate reductase C677T mutation in patients with alopecia areata in Turkish population.
Kalkan G; Yigit S; Karakuş N; Ateş O; Bozkurt N; Ozdemir A; Pancar GŞ
Gene; 2013 Nov; 530(1):109-12. PubMed ID: 23954881
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the monocyte chemoattractant protein 1 -2518 promoter polymorphism in Korean patients with alopecia areata.
Hong SB; Jin SY; Park HJ; Jung JH; Sim WY
J Korean Med Sci; 2006 Feb; 21(1):90-4. PubMed ID: 16479072
[TBL] [Abstract][Full Text] [Related]
13. Follow-up study of the first genome-wide association scan in alopecia areata: IL13 and KIAA0350 as susceptibility loci supported with genome-wide significance.
Jagielska D; Redler S; Brockschmidt FF; Herold C; Pasternack SM; Garcia Bartels N; Hanneken S; Eigelshoven S; Refke M; Barth S; Giehl KA; Kruse R; Lutz G; Wolff H; Blaumeiser B; Böhm M; Blume-Peytavi U; Becker T; Nöthen MM; Betz RC
J Invest Dermatol; 2012 Sep; 132(9):2192-7. PubMed ID: 22534877
[TBL] [Abstract][Full Text] [Related]
14. Genetic evidence for the involvement of NOTCH4 in rheumatoid arthritis and alopecia areata.
AlFadhli S; Nanda A
Immunol Lett; 2013 Feb; 150(1-2):130-3. PubMed ID: 23318300
[TBL] [Abstract][Full Text] [Related]
15. The non-synonymous C1858T substitution in the PTPN22 gene is associated with susceptibility to the severe forms of alopecia areata.
Kemp EH; McDonagh AJ; Wengraf DA; Messenger AG; Gawkrodger DJ; Cork MJ; Tazi-Ahnini R
Hum Immunol; 2006 Jul; 67(7):535-9. PubMed ID: 16829308
[TBL] [Abstract][Full Text] [Related]
16. CTLA-4 gene variants are not associated with Behçet's disease or its clinical manifestations.
Touma Z; Hamdan A; Shamseddeen W; Nasr J; Makhoul N; Zalloua PA; Arayssi T
Clin Exp Rheumatol; 2008; 26(4 Suppl 50):S132. PubMed ID: 19026137
[No Abstract] [Full Text] [Related]
17. Hypothesis testing: CTLA4 co-stimulatory pathways critical in the pathogenesis of human and mouse alopecia areata.
Sundberg JP; McElwee KJ; Carroll JM; King LE
J Invest Dermatol; 2011 Nov; 131(11):2323-4. PubMed ID: 21753782
[No Abstract] [Full Text] [Related]
18. Association of HSPA1B SNP rs6457452 with Alopecia Areata in the Korean population.
Seok H; Jeon HS; Park HJ; Kim SK; Choi JH; Lew BL; Chung JH; Sim WY
Immunol Invest; 2014; 43(3):212-23. PubMed ID: 24303776
[TBL] [Abstract][Full Text] [Related]
19. Resistance to alopecia areata in C3H/HeJ mice is associated with increased expression of regulatory cytokines and a failure to recruit CD4+ and CD8+ cells.
McElwee KJ; Hoffmann R; Freyschmidt-Paul P; Wenzel E; Kissling S; Sundberg JP; Zöller M
J Invest Dermatol; 2002 Dec; 119(6):1426-33. PubMed ID: 12485450
[TBL] [Abstract][Full Text] [Related]
20. PTPN22 gene polymorphism in Egyptian alopecia areata patients and its impact on response to diphencyprone immunotherapy.
El-Zawahry BM; Azzam OA; Zaki NS; Abdel-Raheem HM; Bassiouny DA; Khorshied MM
Gene; 2013 Jul; 523(2):147-51. PubMed ID: 23570882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
